His current research involves the development of health-economic models to evaluate the efficiency of infectious disease surveillance and control interventions, with a focus on antimicrobial resistance, Covid-19 and healthcare-associated infections. He is particularly interested in using transmission modelling within health-economic evaluations to inform intervention design, including the optimisation of SARS-CoV-2 surveillance programmes and the setting of reduction targets for inappropriate antibiotic prescribing.